# Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

> **NCT00579423** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Prostate
- Cancer

## Interventions

- **BIOLOGICAL:** QS21

## Key facts

- **NCT ID:** NCT00579423
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2003-05
- **Final completion:** 2009-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00579423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00579423, "Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00579423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*